http://orcid.org/0000-0001-8821-3622
About the Authors
- Peter Marx
-
Contributed equally to this work with: Peter Marx, Peter Antal
* E-mail: marxp@mit.bme.hu (PM); gabriella.juhasz@manchester.ac.uk (GJ)
Affiliations MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary, Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary
- Peter Antal
-
Contributed equally to this work with: Peter Marx, Peter Antal
Affiliation Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary
- Bence Bolgar
-
Affiliation Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary
- Gyorgy Bagdy
-
Affiliations MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary, Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary, NAP-A-SE New Antidepressant Target Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary
- Bill Deakin
-
Affiliation Neuroscience and Psychiatry Unit, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK and Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK
- Gabriella Juhasz
-
* E-mail: marxp@mit.bme.hu (PM); gabriella.juhasz@manchester.ac.uk (GJ)
Affiliations MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary, Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary, Neuroscience and Psychiatry Unit, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK and Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK, MTA-SE-NAP B Genetic Brain Imaging Migraine Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary
Competing Interests
BD has variously performed consultancy, speaking engagements, and research for Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Schering Plough, Janssen-Cilag, and Servier (all fees are paid to the University of Manchester to reimburse them for the time taken); he also has share options in P1vital. The other authors report no conflict of interest.
Author Contributions
Conceptualization: BD GJ PA GB. Data curation: PM PA GJ. Formal analysis: PM PA BB. Funding acquisition: BD GJ PA. Investigation: PM PA BB. Methodology: PM PA. Project administration: GJ PA BD. Software: PM PA. Supervision: BD GB GJ PA. Validation: GJ PA. Visualization: PM PA GJ. Writing – original draft: PM PA GJ. Writing – review & editing: PM PA GJ BD BB GB.